General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Direct Share Purchase Plan

Directives for the Novartis Direct Share Purchase Plan

For step-by-step instructions on how to apply for and participate in the Novartis Direct Share Purchase Plan, download the document below.

Application to Participate in the Novartis Direct Share Purchase Plan

If you are already or wish to become a Novartis shareholder, you may enroll in the plan by completing an application to participate in the Novartis Direct Share Purchase Plan and reading the directives and the regulations for the Direct Share Purchase Plan.

The Direct Share Purchase Plan is open to investors resident in Switzerland

Order to a bank to deliver Novartis Shares from a Deposit Account

English (0.1 MB)

Deutsch (0.1 MB)

Français (0.1 MB)

Sale Order (Order to sell at best)

Stock chart
Q3 Results 2013

On Thursday, April 24, Novartis will announce its results for the first quarter of 2014